Ken Marek

Precompetitive Data Sharing as a Catalyst to Address Unmet Needs in Parkinson’s Disease

Arthur W. Toga, Max A. Little, Margaret Sutherland, 2015, Journal of Parkinson's disease.

(123I) beta-CIT and single-photon emission computed tomographic imaging vs clinical evaluation in Parkinsonian syndrome: unmasking an early diagnosis.

David Oakes, John P Seibyl, D. Jennings, 2004, Archives of neurology.

In Vivo Assessment and Dosimetry of 2 Novel PDE10A PET Radiotracers in Humans: 18F-MNI-659 and 18F-MNI-654

Olivier Barret, Gilles Tamagnan, John Seibyl, 2014, The Journal of Nuclear Medicine.

First in vivo assessment of two PDE10 tracers [18F]MNI654 and [18F]MNI659

Olivier Barret, Gilles Tamagnan, John Seibyl, 2012 .

Potential of Low Dose Leuco-Methylthioninium Bis(Hydromethanesulphonate) (LMTM) Monotherapy for Treatment of Mild Alzheimer’s Disease: Cohort Analysis as Modified Primary Outcome in a Phase III Clinical Trial

Giovanni B. Frisoni, John Seibyl, Roger T. Staff, 2017, Journal of Alzheimer's disease : JAD.

Diagnosis of Parkinson's disease on the basis of clinical and genetic classification: a population-based modelling study

Margaret Sutherland, John P A Ioannidis, Daniel Weintraub, 2015, The Lancet Neurology.

Movement Disorder Society Unified Parkinson Disease Rating Scale experiences in daily living: Longitudinal changes and correlation with other assessments

Anthony E. Lang, David Oakes, Bernard Ravina, 2013, Movement disorders : official journal of the Movement Disorder Society.

Targeting Prodromal Alzheimer Disease With Avagacestat: A Randomized Clinical Trial.

John Seibyl, Vladimir Coric, Hilkka Soininen, 2015, JAMA neurology.